iMedic.health

Amiodarone and Simvastatin: Drug Interaction Guide

Quick answer: This is a major interaction — avoid combining Amiodarone and Simvastatin unless specifically directed by your doctor.

Interaction severity: Major — avoid combination

How Amiodarone interacts with Simvastatin

Amiodarone inhibits CYP3A4 metabolism of simvastatin, increasing systemic exposure and the risk of myopathy and rhabdomyolysis.

What you should do

Limit simvastatin dose to 20 mg/day when co-administered with amiodarone, or switch to pravastatin or rosuvastatin.

Key facts

Severity

Major — avoid combination

Mechanism

Amiodarone inhibits CYP3A4 metabolism of simvastatin, increasing systemic exposure and the risk of myopathy and rhabdomy...

Action

Limit simvastatin dose to 20 mg/day when co-administered with amiodarone, or switch to pravastatin or rosuvastatin.

Important medical disclaimer: This page provides educational information about drug interactions for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your specific medications with a qualified healthcare provider before starting, stopping, or changing any treatment. About our editorial team.

Frequently asked questions

Can I take Amiodarone and Simvastatin together?

No — this combination should generally be avoided. Limit simvastatin dose to 20 mg/day when co-administered with amiodarone, or switch to pravastatin or rosuvastatin.

What is the severity of this interaction?

The interaction between Amiodarone and Simvastatin is classified as Major — avoid combination. Amiodarone inhibits CYP3A4 metabolism of simvastatin, increasing systemic exposure and the risk of myopathy and rhabdomyolysis.

What should I do if I'm prescribed both?

Limit simvastatin dose to 20 mg/day when co-administered with amiodarone, or switch to pravastatin or rosuvastatin. Always consult your prescribing clinician — do not stop or change medications without medical guidance.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.